NNNNNNNNNNNNNNNN
SEAnews SEA Research, BLK 758 Yishun Street 72 #09-444 Singapore 760758
India Front Line Report
SEAnews Issue:monthly
tel:65-87221054
NNNNNNNNNNNNNNN
2020-06-24 ArtNo.46804
◆Semiconductor assembly majors plan to set up manufacturing units in India




【New Delhi】Four top global companies in the assembly, testing, marking, and packaging (ATMP) business have had discussions with the government to set up their manufacturing units and develop export hubs to undertake outsourced semiconductor packaging and test services.
 The companies —Taiwanese majors ASE Technology Holding (with revenues of $11.87 billion), Powertech Technology Inc ($2.17 billion), and SPIL ($2.79 billion), and US-based Amkor Technology ($4.31 billion) — plan to take advantage of the incentive schemes recently announced by the government.

○Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila




【Ahmedabad】After Cipla, Jubilant Lifesciences and Hetero Labs, Gilead Sciences Inc., headquartered in Foster City, California, USA, has now signed a non-exclusive licensing agreement with Cadila Healthcare Ltd (Zydus Cadila) for manufacturing and distribution of its investigational drug Remdesivir for treating Covid-19.
 After being issued an Emergency Use Authorization by the US Food and Drug Administration (FDA) for Remdesivir to treat patients suffering from severe symptoms of novel coronavirus (Covid-19), Gilead has entered India through such agreements with domestic players.
 The Indian drug maker will receive the know-how from Gilead Sciences Inc, to manufacture the API for Remdesivir and also to make the finished product and market it in 127 countries, including India.
 Under the agreement, the license is royalty free until another pharmaceutical product or vaccine is approved for the treatment or prevention of Covid-19 by the USFDA or EMA or the WHO announcing the end of the public health emergency.

【News source】

Semiconductor assembly majors plan to set up manufacturing units in India

Top 10 OSAT Companies in World

Gilead finds fourth partner for manufacture of Remdesivir in Zydus Cadila

○One world:AD-SEAnews


AD-SEAnews, New concept of SEAnews, aims to realize borderless one world.



Your Comments / Unsubscribe










width="200" border="0">




SEAnews Messenger



SEAnewsFacebook



SEAnews eBookstore



SEAnews world circulation


[Your Comments / Unsubscribe]/[您的意见/退订]/[ご意見/配信停止]
Please do not directly reply to the e-mail address which is used for delivering the newsletter.
请别用递送新闻的邮件地址而直接回信。
メールをお届けした送信専用アドレスには返信しないで下さい。
SEAnews 掲載記事の無断転載を禁じます。すべての内容は日本の著作権法並びに国際条約により保護されています。
Copyright 2003 SEAnews® All rights reserved. No reproduction or republication without written permission.